Home
October 2009 November 2009 December 2009
Su Mo Tu We Th Fr Sa
Week 45 1 2 3 4 5 6 7
Week 46 8 9 10 11 12 13 14
Week 47 15 16 17 18 19 20 21
Week 48 22 23 24 25 26 27 28
Week 49 29 30

Effect of Nightly versus On Demand Vardenafil on Recovery of Erectile Function in Men Following Bilateral Nerve-Sparing Radical Prostatectomy - Abstract Show Comments PDF Print E-mail
  
Monday, 28 July 2008

Universita Vita Salute San Raffaele, Milan, Italy.

To date, no data have been available from large, well-designed trials comparing on demand and nightly dosing of phosphodiesterase type 5 (PDE5) inhibitors on recovery of erectile function in postprostatectomy patients with erectile dysfunction (ED).

To investigate the effect of early postoperative dosing with vardenafil, administered either nightly or on demand, compared with placebo on recovery of erectile function in men with ED following bilateral nerve-sparing radical prostatectomy (NSRP) surgery.

A randomised, double-blind, double-dummy, multicentre, parallel group study conducted at 87 centres across Europe, Canada, South Africa, and the United States. For inclusion, patients had to be scheduled to undergo bilateral NSRP within 1 mo of screening and have a normal International Index of Erectile Function erectile function domain (IIEF-EF) score of >/=26 at screening. A total of 628 men, aged 18-64 yr, were randomised to treatment. Study design consisted of a 9-mo double-blind treatment period, a 2-mo single-blind washout period, and an optional 2-mo open-label period.

Patients received placebo, nightly vardenafil, or on demand vardenafil.

Primary outcome measure was the percentage of subjects with an IIEF-EF score of >/=22 after the 2-mo washout period. Secondary variables included mean per-patient success rates for Sexual Encounter Profile (SEP) questions 2 and 3.

No statistically significant differences were observed among treatment groups in the proportion of patients with an IIEF-EF score of >/=22 or in SEP3 success rates after the washout period. On demand vardenafil treatment resulted in significantly greater IIEF-EF scores and better SEP3 response rates than placebo over the entire treatment period.

In this study of men with ED following bilateral NSRP, vardenafil was efficacious when used on demand, supporting a paradigm shift towards on demand dosing with PDE5 inhibitors in this patient group.

Written by
Montorsi F, Brock G, Lee J, Shapiro J, Stief C.

Reference
Eur Urol. 2008 Jul 9. Epub ahead of print.
doi:10.1016/j.eururo.2008.06.083

PubMed Abstract
PMID:18640769

UroToday.com Erectile Dysfunction (ED) Section

 

Reader Comments

Please log-in or register in order to submit comments.

Powered by AkoComment!

 
User Rating: / 1
PoorBest


 
Visitor Ratings:
Patients:
5 (1 votes)


Bookmark and Share

Member's Section

Login

Sign Up

Quick Search